跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Differin
Approved
STANDARD
Differin
Galderma Brasil Ltda.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1bb12dbdf626f0ef
Company
Galderma Brasil Ltda.
Type
Standard
Approval Details
Approval Id
1bb12dbdf626f0ef
Drug Approval Philippines Name
Differin
Product Name
Differin
Registration Number
DR-XY43033
Brand Name
Differin
Generic Name
Adapalene
Dosage Form
Topical Gel
Dosage Strength
3mg/g (0.3%)
Manufacturer
Galderma Brasil Ltda.
Importer
Galderma Philippines Inc.
Distributor
Galderma Philippines Inc.
Company Detail Path
/organization/galderma-brasil-ltda
Issuance Date
15 February 2024
Expiry Date
28 November 2028
Pharmacologic Category
Anti-acne
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1bb12dbdf626f0ef
Type
Standard
Back to Philippines FDA Approvals
Differin - Philippines FDA Drug Approval Details